The MARKETING RESEARCH BUREAU (MRB), an independent company founded in 1974 is the premier supplier of market data on the blood and plasma industry on a global level. Over the years, it has become a trusted source of information in this industry and now counts all the major plasma products manufacturers among its regular clients. Its database spans over several decades, and includes product prices, volumes, market shares, and forecasts. It has accumulated an in-depth knowledge of all aspects of the global industry, from blood and plasma collections to manufacturing and worldwide distribution of plasma-derived drugs. If you are looking for comprehensive, accurate current and historical data on this multi-billion dollar industry, contact the MRB.

The MRB published its first report on The Plasma Proteins Market in the United States in1974, and continues to publish it annually. This report has become an essential reference for the plasma industry and other stakeholders involved in this highly specialized field. In addition to analyzing the sales of all the plasma-derived and recombinant therapeutic proteins commercialized in the United States, this report covers plasma collection and fractionation, R&D, and includes the profiles of the companies active in this industry in the U.S.

Each year, the MRB also publishes a market study on the therapeutic plasma proteins market in a different region on a rotation basis (Europe, Asia & Pacific, Middle East, Latin America, etc.). This report comprises country chapters organized in the format below. Approximately 70 countries are surveyed over a three-year period. Additionally, the data from the regional reports are compiled every other year in another syndicated publication titled The Worldwide Plasma Proteins Market.

Every three years, theMARKETING RESEARCH BUREAU publishes an International Directory of Plasma Fractionators which lists all the commercial firms and non-profit organizations involved in the processing of human plasma into therapeutic products. This report details their contact information, plasma processing capacity and throughput, and product portfolio, as well as the plasma supply by type and origin. This report is complemented by a five-year forecast of plasma fractionation capacities and plasma throughput by company.

Since 1984, the MARKETING RESEARCH BUREAU has published International Blood/Plasma News, a monthly newsletter covering business, scientific and technological events in the blood and plasma fields. IB/PN features major industry events, new products and processes, research & development, product safety, pricing, patents, and more. The current and all back issues are available as hard copy or in pdf format.

Besides its regional market analyses, the MRB prepares other syndicated studies and forecasts on specific products such as albumin, polyvalent immune globulin (IgG), coagulation factors, fibrinogen C-1 Inhibitor, blood collections and component productions, etc.

For clients with specific information needs, the MRB can undertake customized market research projects, including country market forecasts, product introduction scenarios, market intelligence, etc.

The MRB always selects the approach and methodology best suited for each research project. Its comprehensive database facilitates the analysis of market trends and company strategies. This database is consistently enriched with new data and information based on countries surveys. In all its research, the MRB abides by the current market research standards, professional rules and ethical values, and maintains the highest levels of objectivity and accuracy, as well as cost effectiveness.

 

TABLE OF CONTENTS OF A SAMPLE COUNTRY CHAPTER

 

EXECUTIVE SUMMARY

HEALTH CARE ENVIRONMENT

BLOOD AND PLASMA COLLECTIONS

PLASMA FRACTIONATION

MARKET OVERVIEW

INTRAMUSCULAR IMMUNE GLOBULIN MARKET

Polyvalent Intramuscular Immune Globulin

Tetanus Immune Globulin

RhoD Immune Globulin

Rabies immune Globulin

Hepatitis B Immune Globulin

Other Hyperimmune Globulin

INTRAVENOUS & SUBCUTANEOUS IMMUNE GLOBULIN MARKET

ALBUMIN MARKET

HEMOPHILIA CARE AND COAGULATION MARKET

Demographic Data on Hemophilia

Hemophilia Treatment

Factor VIII

Factor IX

Inhibitor

Von Willebrand Disease

Prothrombin Complex Concentrate

New Hemophilia Therapies

OTHER PLASMA PRODUCTS

Apha-1 Antitrypsin

C-1 Inhibitor

Fibrinogen

Fibrin Adhesives

Antithrombin III

REGISTRATION & REGULATIONS

PRICING & DISTRIBUTION

MARKET TRENDS & THREE-YEAR FORECAST

MAJOR COMPANIES AND ORGANIZATIONS